Cortical structural abnormalities in deficit versus nondeficit schizophrenia

scientific article published on 13 February 2012

Cortical structural abnormalities in deficit versus nondeficit schizophrenia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.SCHRES.2012.01.030
P8608Fatcat IDrelease_sfiqkhwjjrba7k3yot6itbjcdu
P932PMC publication ID3298625
P698PubMed publication ID22336954
P5875ResearchGate publication ID221834753

P50authorCelso ArangoQ5058454
Godfrey D. PearlsonQ21114976
Brian KirkpatrickQ62574216
Robert W. BuchananQ109937282
P2093author name stringBernard A Fischer
Robert P McMahon
William T Carpenter
Walter A Meyer
William R Keller
Alan Francis
P2860cites workNeuropsychology of the deficit syndrome: new data and meta-analysis of findings to dateQ31084441
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.Q33814201
Prefrontal, parietal, and temporal cortex networks underlie decision-making in the presence of uncertaintyQ33929408
The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeysQ33985626
A separate disease within the syndrome of schizophreniaQ34140437
Language processing: functional organization and neuroanatomical basisQ34931323
Improving stereological estimates for the volume of structures identified in three-dimensional arrays of spatial dataQ36881469
Patterns of structural MRI abnormalities in deficit and nondeficit schizophreniaQ37076288
Are there theory of mind regions in the brain? A review of the neuroimaging literatureQ37335228
Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functionsQ37800377
Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit SyndromeQ41127141
A Tc-99m HMPAO SPECT study of regional cerebral blood flow in drug-free schizophrenic patients with deficit and non-deficit syndromeQ44555847
Gray-matter abnormalities in deficit schizophreniaQ48207878
Topographical variation of the human primary cortices: implications for neuroimaging, brain mapping, and neurobiologyQ48252744
Structural abnormalities in deficit and nondeficit schizophreniaQ48365695
Structural evaluation of the prefrontal cortex in schizophreniaQ48413878
Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition taskQ48722393
The Schedule for the Deficit syndrome: an instrument for research in schizophreniaQ48914414
Clinical correlates of the deficit syndrome of schizophreniaQ49075231
Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptomsQ49078641
Patterns of cranial, brain and sulcal CSF volumes in male and female deficit and nondeficit patients with schizophrenia.Q51719112
Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia.Q51979486
Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia.Q52056404
Morphometric Assessment of the Heteromodal Association Cortex in SchizophreniaQ58793615
Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtypeQ71569702
Attentional impairments in deficit and nondeficit forms of schizophreniaQ73120148
P433issue1-3
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
P304page(s)51-54
P577publication date2012-02-13
P1433published inSchizophrenia ResearchQ7431607
P1476titleCortical structural abnormalities in deficit versus nondeficit schizophrenia
P478volume136

Reverse relations

cites work (P2860)
Q41061357A New Division of Schizophrenia Revealed Expanded Bilateral Brain Structural Abnormalities of the Association Cortices
Q38782257A Review of Anticipatory Pleasure in Schizophrenia
Q37602601A review of reward processing and motivational impairment in schizophrenia
Q88607265Altered brain gyrification in deficit and non-deficit schizophrenia
Q38954278An Affective Neuroscience Model of Impaired Approach Motivation in Schizophrenia.
Q35738993Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models
Q38559235Avolition, Negative Symptoms, and a Clinical Science Journey and Transition to the Future.
Q85839759Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment
Q48016632Convergence and Divergence of Brain Network Dysfunction in Deficit and Non-deficit Schizophrenia
Q89490494Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation
Q36877510Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia.
Q47898982Mapping Convergent and Divergent Cortical Thinning Patterns in Patients With Deficit and Nondeficit Schizophrenia.
Q92856649Maternal Pregnancy-Related Anxiety Is Associated With Sexually Dimorphic Alterations in Amygdala Volume in 4-Year-Old Children
Q35176772Motor abnormalities and basal ganglia in schizophrenia: evidence from structural magnetic resonance imaging
Q50420417Multivariate Associations Among Behavioral, Clinical, and Multimodal Imaging Phenotypes in Patients With Psychosis.
Q47575357Neural substrate of unrelenting negative symptoms in schizophrenia: a longitudinal resting-state fMRI study
Q35779544Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables
Q48076142Neurocognitive impairment in the deficit subtype of schizophrenia
Q38675564Primary, Enduring Negative Symptoms: An Update on Research
Q37602615Progress in the study of negative symptoms
Q41046867Reinforcement Learning Performance and Risk for Psychosis in Youth
Q88740592Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Individuals With Schizophrenia Spectrum Disorder and Healthy Control Subjects
Q52676587TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia.
Q52985640[Negative symptoms and cerebral imaging].

Search more.